Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Neuropsychological performance in African children with HIV enrolled in a multicentre anti-retroviral clinical trial

Trial Profile

Neuropsychological performance in African children with HIV enrolled in a multicentre anti-retroviral clinical trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2018

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Nevirapine (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Mar 2018 Results (n=615) assessing neuropsychological outcomes at enrollment (> 5 yrs age) among HIV+, HIV-uninfected perinatally-exposed (HEU), and HIV unexposed (HU) children from 6 sub-Saharan countries, were presented at the 25th Conference on Retroviruses and Opportunistic infections.
    • 16 Nov 2017 New trial record
    • 02 Nov 2017 Results published in the AIDS
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top